CLEIA (Chemiluminescent enzyme immunoassay) A method in which an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, a chemiluminescent substrate is added and the luminescence intensity is measured.
4.0-82.1(pg/mL)
Aldosterone〔CLEIA〕
Serum
0.5
S09 ↓ A00
(21 days)
2-4
CLEIA
CLEIA (Chemiluminescent enzyme immunoassay) A method in which an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, a chemiluminescent substrate is added and the luminescence intensity is measured.
4.0-82.1(pg/mL)
Aldosterone〔CLEIA〕
Urine storage
1.5
A00
(21 days)
5-7
CLEIA
CLEIA (Chemiluminescent enzyme immunoassay) A method in which an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, a chemiluminescent substrate is added and the luminescence intensity is measured.
1.0-19.3(μg/day)
Active renin concentration(ARC)〔CLEIA〕
Plasma
0.5
PN2,PN5 ↓ A00
(21 days)
2-4
CLEIA
CLEIA (Chemiluminescent enzyme immunoassay) A method in which an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, a chemiluminescent substrate is added and the luminescence intensity is measured.
2.21-39.5(pg/mL)
Plasma renin activity (PRA)〔EIA〕
Plasma
0.7
PN2,PN5 ↓ A00
(14 days)
3-5
Enzyme immunoassay(EIA)
EIA (Enzyme Immunoassay Assay) Enzyme immunoassay The principle of measurement is the same as that of RIA. An antigen-antibody reaction is performed using an antigen or antibody labeled with an enzyme to a labeled substance, and a chromogenic substrate is added to measure enzyme activity.
Lying position 0.2-2.3 Sitting position 0.2-3.9 Standing position 0.2-4.1 (ng/mL/hr)
Aldosterone 〔CLEIA〕/renin concentration ratio
Plasma
1.0
PN2,PN5 ↓ A00
(21 days)
2-4
CLEIA
CLEIA (Chemiluminescent enzyme immunoassay) A method in which an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, a chemiluminescent substrate is added and the luminescence intensity is measured.
See below
Aldosterone 〔CLEIA〕/renin activity ratio
Plasma
1.2
PN2,PN5 ↓ A00
(14 days)
3-5
Aldosterone: CLEIA Renin activity: EIA
See below
Cyclic AMP
Plasma
0.3
PN2,PN5 ↓ A00
(1 month)
Please confirm in advance
RIA DCC method
RIA (Radio immunoassay) Radioimmunoassay A method to perform the competitive antigen-antibody reaction between the antigen labeled with radioisotope (RI) against the antibody and the antigen in the specimen, and to separate the labeled antigen bound to the antibody (bound type: Bound) from the labeled antigen not bound to the antibody (free type: Free) and to measure the ratio of them as the antigen concentration from the radioactivity. As separation methods for bound and free types (B/F separation), there are the solid-phase method in which the antibody is solid-phased, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, the ammonium sulfate precipitation method in which the antigen-antibody complex is precipitated with ammonium sulfate (ammonium sulfate), and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.
11-21(pmol/mL)
Cyclic AMP
Urine storage
1.0
U00
Please confirm in advance
RIA DCC method
RIA (Radio immunoassay) Radioimmunoassay A method to perform the competitive antigen-antibody reaction between the antigen labeled with radioisotope (RI) against the antibody and the antigen in the specimen, and to separate the labeled antigen bound to the antibody (bound type: Bound) from the labeled antigen not bound to the antibody (free type: Free) and to measure the ratio of them as the antigen concentration from the radioactivity. As separation methods for bound and free types (B/F separation), there are the solid-phase method in which the antibody is solid-phased, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, the ammonium sulfate precipitation method in which the antigen-antibody complex is precipitated with ammonium sulfate (ammonium sulfate), and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.
1.8-6.3(μmol/day)
Human atrial natriuretic peptide (HANP)
Plasma
0.5
PAP ↓ A00
(21 days)
2-4
CLEIA
CLEIA (Chemiluminescent enzyme immunoassay) A method in which an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, a chemiluminescent substrate is added and the luminescence intensity is measured.
43.0 or less (pg/mL)
Human brain natriuretic peptide (BNP)
Plasma
0.5
PN2,PN5 ↓ A00
2-4
CLEIA
CLEIA (Chemiluminescent enzyme immunoassay) A method in which an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, a chemiluminescent substrate is added and the luminescence intensity is measured.
18.4 or less (pg/mL)
N-terminal fragment of human brain natriuretic peptide precursor (NTproBNP)
Serum
0.4
S09 ↓ A00
2-4
ECLIA
ECLIA (Electro chemiluminescence immunoassay) Electrochemiluminescence immunoassay A method to measure the luminescence intensity of ruthenium pyridine complexes by electrochemical reaction, in which antibody-conjugated beads are used to react with antigens, followed by a secondary reaction of antibodies labeled with ruthenium pyridine complexes with the antigens.
125 or less (pg/mL)
Erythropoietin
Serum
0.8
S09 ↓ A00
(28 days)
2-4
CLEIA
CLEIA (Chemiluminescent enzyme immunoassay) A method in which an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, a chemiluminescent substrate is added and the luminescence intensity is measured.
4.2-23.7(mIU/mL)
Osteocalcin
Serum
0.3
S09 ↓ A00
2-4
ECLIA
ECLIA (Electro chemiluminescence immunoassay) Electrochemiluminescence immunoassay A method to measure the luminescence intensity of ruthenium pyridine complexes by electrochemical reaction, in which antibody-conjugated beads are used to react with antigens, followed by a secondary reaction of antibodies labeled with ruthenium pyridine complexes with the antigens.
Premenopausal women 7.8-30.8 Postmenopausal women 14.2-54.8 Men 8.4-33.1 (ng/mL)
Undercarboxylated osteocalcin (ucOC)
Serum
0.5
S09 ↓ A00
(21 days)
2-4
ECLIA
ECLIA (Electro chemiluminescence immunoassay) Electrochemiluminescence immunoassay A method to measure the luminescence intensity of ruthenium pyridine complexes by electrochemical reaction, in which antibody-conjugated beads are used to react with antigens, followed by a secondary reaction of antibodies labeled with ruthenium pyridine complexes with the antigens.
Less than 4.50 (ng/mL)
Hepatocyte growth factor (HGF)
Serum
0.3
S09 ↓ A00
(1 month)
2-8
ELISA
ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate.
0.39 or less (ng/mL)
FGF23〔CLEIA〕
Serum
0.4
S09 ↓ A00
(21 days)
2-6
CLEIA
CLEIA (Chemiluminescent enzyme immunoassay) A method in which an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, a chemiluminescent substrate is added and the luminescence intensity is measured.
19.9-52.9(pg/mL)
Adiponectin〔LA〕
Serum
0.5
S09 ↓ A00
2-4
Latex immunoturbidimetry
4.0 or more (μg/mL)
Leptin〔ELISA〕
Serum
0.3
S09 ↓ A00
(7 days)
Please confirm in advance
ELISA
ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate.
M 0.6-8.9 F 1.9-26.6 (ng/mL)
sFlt-1/PlGF ratio
Serum
0.7
S09 ↓ A00
(7 days)
2-6
ECLIA
ECLIA (Electro chemiluminescence immunoassay) Electrochemiluminescence immunoassay A method to measure the luminescence intensity of ruthenium pyridine complexes by electrochemical reaction, in which antibody-conjugated beads are used to react with antigens, followed by a secondary reaction of antibodies labeled with ruthenium pyridine complexes with the antigens.
RIA (Radio immunoassay) Radioimmunoassay A method to perform the competitive antigen-antibody reaction between the antigen labeled with radioisotope (RI) against the antibody and the antigen in the specimen, and to separate the labeled antigen bound to the antibody (bound type: Bound) from the labeled antigen not bound to the antibody (free type: Free) and to measure the ratio of them as the antigen concentration from the radioactivity. As separation methods for bound and free types (B/F separation), there are the solid-phase method in which the antibody is solid-phased, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, the ammonium sulfate precipitation method in which the antigen-antibody complex is precipitated with ammonium sulfate (ammonium sulfate), and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.
Lying position 0.3-2.9 Standing position 0.3-5.4 (ng/mL/hr)
RIA (Radio immunoassay) Radioimmunoassay A method to perform the competitive antigen-antibody reaction between the antigen labeled with radioisotope (RI) against the antibody and the antigen in the specimen, and to separate the labeled antigen bound to the antibody (bound type: Bound) from the labeled antigen not bound to the antibody (free type: Free) and to measure the ratio of them as the antigen concentration from the radioactivity. As separation methods for bound and free types (B/F separation), there are the solid-phase method in which the antibody is solid-phased, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, the ammonium sulfate precipitation method in which the antigen-antibody complex is precipitated with ammonium sulfate (ammonium sulfate), and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.
IRMA (Immuno radio metric assay) Immuno radiometric assay One of the RIA methods in which an antigen is reacted with a solid-phase antibody, followed by a secondary reaction of the antigen with a radioisotope (RI)-labeled antibody. This method is also called the sandwich method because a solid-phase antibody and a labeled antibody bind to each other by sandwiching the antigen.
Any time 3.2-36 lying position 2.5-21 standing position 3.6-64 (pg/mL)
RIA (Radio immunoassay) Radioimmunoassay A method to perform the competitive antigen-antibody reaction between the antigen labeled with radioisotope (RI) against the antibody and the antigen in the specimen, and to separate the labeled antigen bound to the antibody (bound type: Bound) from the labeled antigen not bound to the antibody (free type: Free) and to measure the ratio of them as the antigen concentration from the radioactivity. As separation methods for bound and free types (B/F separation), there are the solid-phase method in which the antibody is solid-phased, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, the ammonium sulfate precipitation method in which the antigen-antibody complex is precipitated with ammonium sulfate (ammonium sulfate), and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.
22 or less (pg/mL)
FGF-23(Suspended beyond orders placed 03-31-2020)
Serum
0.3
S09 ↓ A00
(14 days)
2-8
ELISA
ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate.
IRMA (Immuno radio metric assay) Immuno radiometric assay One of the RIA methods in which an antigen is reacted with a solid-phase antibody, followed by a secondary reaction of the antigen with a radioisotope (RI)-labeled antibody. This method is also called the sandwich method because a solid-phase antibody and a labeled antibody bind to each other by sandwiching the antigen.
CLEIA (Chemiluminescent enzyme immunoassay) A method in which an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, a chemiluminescent substrate is added and the luminescence intensity is measured.
Notifications of URL changes/lab information added
You can now view test items from all labs.
Please choose a lab from the list below.
You can switch between labs as any time using the upper right lab icon.
The domain name of the TEST DIRECTORYpage has changed.
Please update bookmarks and saved links with the new address.
Notifications of URL changes/lab information added
You can now view test items from all labs.
Please choose a lab from the list below.
You can switch between labs as any time using the upper right lab icon.
The domain name of the TEST DIRECTORYpage has changed.
Please update bookmarks and saved links with the new address.